In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasion. This one targeted forthe US audience at 13:00 EST (19:00 CET) The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics. […]
SenzaGen is participating at The Society of Toxicology of Canada 50th Annual Symposium, Winter 2018 WHAT’S IN A NAM ? (NOVEL APPROACH METHODOLOGIES). BENEFITS, LIMITATIONS, TRANSLATION, COMMUNICATION. | DECEMBER 10 TO 12, 2018 | | VENUE: COURTYARD BY MARRIOTT - TORONTO | The Society of Toxicology of Canada Inc. is a non-profit association whose objectives […]
SenzaGen is attending the Training and Knowledge-sharing Workshop - "Applying non-animal strategies for assessing skin sensitization" in Helsinki, Finland. The main objective of the workshop is to discuss how the information produced from non-animal assays for skin sensitisation can be used in regulatory decision-making for hazard identification (classification & labelling) but also for risk assessment decisions, […]
SenzaGen will exhibit at Booth #3652 Share your knowledge at the largest toxicology meeting in the world and get the latest updates on the advances in toxicology by attending the SOT 58 Annual Meeting and ToxExpo, in Baltimore, Maryland, USA. SenzaGen poster sessions at CC Exhibit Hall, further details below: Title: A Novel 68-Gene Biomarker Signature […]
Heading into its 30th edition in 2019, in-cosmetics Global is the leading event for personal care ingredients. The exhibition brings together personal care ingredients suppliers (exhibitors) with finished product manufacturers (visitors), each looking to network, learn about future trends, and discover new products. SenzaGen will participate and attend workshops
EUROPEAN TIMEZONE Are you curious about potential applications of genomics or machine learning? Have you ever wondered how the GARD test platform works? This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers. This […]
AMERICAN TIMEZONE 2 am EDT Are you curious about potential applications of genomics or machine learning? Have you ever wondered how the GARD test platform works? This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and […]
Presentation by Dr. Andy Forreryd Session: Developing in vitro based alternatives to animal testing Date: 13 June Time: 14:00-15:30 Chair: Prof. Juliette Legler Speakers: Dr. Ivan Kopljar, Dr. Peter Racz, Dr. Andy Forreryd The 40th NVT annual meeting will be all about innovation through integration. We will be looking to identify the gaps between academia, […]
GARD™air - An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning Presenter: Joshua Schmidt, SenzaGen Inc., USA Co-author: Andy Forreryd, SenzaGen AB, Lund, Sweden Registration link: https://attendee.gotowebinar.com/register/2480462347058889485
IUTOX and the Society of Toxicology, USA (SOT) are pleased to announce the next triennial International Congress of Toxicology (ICT) to be held July 15–18, 2019, at the Hawaii Convention Center in Honolulu, Hawaii, USA—a forum for scientists in academia, government, and industry from around the world to learn about the latest developments in toxicological […]
